Volume 10, Number 10, October 2004

Molecular Evidence of Interhuman Transmission of Pneumocystis Pneumonia among Renal Transplant Recipients Hospitalized with HIV-Infected Patients

Meja Rabodonirina,* Philippe Vanhems,†§ Sandrine Couray-Targe,‡ René-Pierre Gillibert,† Christell Ganne,‡ Nathalie Nizard,† Cyrille Colin,‡ Jacques Fabry,†§ Jean-Louis Touraine,§ Guy van Melle,¶ Aimable Nahimana,¶ Patrick Francioli,¶ and Philippe M. Hauser¶
*Hôpital de la Croix-Rousse, Lyon, France; †Université Claude Bernard and INSERM U271, Lyon, France; ‡Hospices Civils de Lyon, Lyon, France; §Hôpital Edouard-Herriot, Lyon, France; and ¶Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Figure 1. Pneumocystis jirovecii pneumonia (PCP) cases in HIV-infected patients (white bars) and in transplant recipients (black bars) at building A of Edouard-Herriot Hospital. Solid lines show the number of hospital patient-days for transplant recipients (filled squares), for HIV-infected patients (filled triangles), and for the patients during their PCP episode (crosses), as well as the number of renal transplantations performed (white squares). HAART, highly active antiretroviral therapy.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed September 21, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention